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Abstract

COMPARISON AND CORRELATION OF FOUR METHODS OF MEASURING
IMMUNITY TO HUMAN CYTOMEGALOVIRUS
by
James A. Brandt

The complement fixation test (CF) is currently the test most often
used to determine the presence of antibody to human Cytomegalovirus (CMV).
Several more recent techniques have now been adapted for this purpose.

A

comparison of CMV antibody titers was made between the CF test, a commer
cially available enzyme-linked immunosorbent assay (ELISA), an indirect
immunoflucrescent technique (IFA), and a modified indirect hemagglutination
test (IHA).

Forty three serum samples were tested for antibodies to CMV by

each of the above procedures.

The ELISA, IFA, and IHA titers were in close

agreement on all samples tested.

The ELISA, IFA, and IHA titers were all

equal to or greater than the CF titer for 38 of the 43 samples (88%).

Two

samples were anticomplementary in the CF test but gave readable results in
the other procedures.
of the other tests.
examined.

Two samples with low CF titers were negative in each
The CF test was the least sensitive of the procedures

The commercial ELISA system appeared to be the most practical

method and offered the highest degree of sensitivity in detecting anti
bodies to CMV.
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It is now recognized that Cytomegalovirus . (CMV) infection can be acThe possibility of transmitting

quired as a result of blood transfusion.

CMV via blood donors with latent CMV infection was suggested as early as
1951 (1).

Subsequently, an infectious mononucleosis-like illness identi-

fied as a postperfusion syndrome was shown to be caused by CMV (2,3).
Convincing evidence for blood as a source of CMV has been reported since
that time (4).
More recent studies have shown that up to 25% of exchange-transfused
In one study, 13.5% of infants

newborns may develop CMV infections (5).

of CMV seronegative mothers developed infection when exposed to at least
Fatal or ser

one donor with, serologic evidence of latent CMV infection.

ious symptoms developed in 50% of these infected infants who had received
more than 50 ml of packed red blood cells.

It was shown that the use of

CMV seronegative donors virtually eliminated transfusion-acquired CMV in
fections in this group of subjects (6).
CMV appears to be associated with leukocyte-rich fractions of fresh
whole blood in various reports (7,8,9).

Evidence also indicated that the

granulocyte fraction is more closely associated with CMV than is the mono
nuclear fraction (8).

Complicating the picture is the additional finding

that CMV has been recovered from the erythrocyte, plasma, and serum frac
tions of blood as well as from cerebrospinal fluid (10,11).

The solu

tions offered to the problem of transfusion-acquired CMV infection have
focused primarily on the use of- leukocyte-poor blood or the use of don
ors who have no serologic evidence of antibodies to CMV.
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Of these
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approaches to the problem, the use of CMV seronegative blood appears in
most cases to be the most practical procedure.
The intent of this study was to evaluate and compare several current
methods for detecting the presence of antibody to CMV.

The overall pur-

pose was to determine the most practical method for clinical laboratories
to screen blood used to transfuse certain "high risk" patients.

The com

plement fixation test (CF) was chosen as the standard for comparison be
cause of it's longstanding and widespread use.

lt is the most commonly

used test for detecting the presence of antibody to CMV.

The indirect

fluorescent antibody technique (IFA), a modified indirect hemagglutination
test (IHA), and a commercially available enzyme-linked immunosorbent assay
(ELISA) were chosen as examples of more recent techniques that are curr
ently in use and may offer certain advantages over the CF test.
The data demonstrate that for the majority of samples tested each
method gave approximately the same qualitative result, either positive or
negative for the presence of antibody to CMV.

The CF test appeared less

sensitive than the other methods examined and consistently gave lower
titers.
other.

The IFA, IHA, and ELISA assays were in close agreement with each
The commercial ELISA technique was shown to be the most sensitive

procedure by demonstrating the highest antibody titers to CMV and in add
ition, appeared to be the easiest to set up and interpret.

MATERIALS AND METHODS
Sera Selection
Sera used were selected from those submitted to the diagnostic
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virology laboratory at Loma Linda University Medical Center for determination of antibody titers to CMV.

All sera had been previously tested for

CMV antibody by the CF method and were stored frozen at -20°C.

Sera were

selected to include samples showing no anti-CMV activity as well as sampies representing low, medium, and high titers to CMV.

Ten of the samples

represented paired sera (acute and convalescent) and thirty three were
single serum samples.
Complement Fixation Assay
CF tests were done by a standard microtiter method (12) using 2 units of antigen.

Antigen standardization was accomplished by testing ser-

ial twofold dilutions of immune serum to determine the optimal dilution
of antigen which gave fixation.

A commercial antigen prepared from CMV

strain AD-169 was used (Flow Laboratories, Inglewood, Calif. Lot #33015).
Guinea pig complement (Lot #31009), hemolysin (rabbit anti-sheep erythro
cyte serum Lot # 4788), CMV antigen control (Lot #33471), and sheep red
blood cells (Lot #A4892) were also obtained from the same manufacturer.
Serum titers were expressed as the reciprocal of the highest dilution in
which 70% or more of the sheep red blood cells are not hemolysed.

No

hemolysis indicates a positive test.
Enzyme-Linked Immunosorbent Assay
Detection of antibody by the CMV BIO-BEAD TITRATION KIT (Litton Bionetics, Kensington, Md.) is based on the principle of solid phase immunoassay.

A magnetic transfer device, available from the same manufacturer.

is used to transfer the solid phase from one reaction mixture to another.
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All reagents, controls, and equipment for performing the test were supp
lied by the manufacturer.
Ferrous metallic beads with bound CMV antigen from infected cell
cultures were used in the test.

The beads were placed in the dilution

of serum to be assayed and specific antibodies, if present, would attach
themselves to the antigens bound to the beads.

The beads were washed to

remove unbound human serum proteins and then released into a reaction
mixture containing peroxidase conjugated to goat anti-human immunoglobulins.

The conjugate attached to the patient's antibody if the patient's

antibody was attached to the CMV antigen on the beads.

The beads were

then washed to remove unbound conjugate and placed into a substrate sol
ution (0.03% 2,21-Azino-di-3-ethyl-benzthiazoline-sulfonate-6).

The app

earance of a green color indicated the presence of human antibody to the
antigens on the beads.
The antibody titer was determined as the highest dilution of serum
in which a 1+ to 2+ green color developed with the antigen coated bead.
The degree of color development was compared to that yielded by the positive control sera at the stated titers.

A definite but light green col-

or was considered to be a 1+ to 2+ reaction and a dark green color was
read as a 3+ to 4+ reaction.

For the purposes of this study, the proced-

ure as outlined by the manufacturer (package insert; CMV BIO-BEAD TITRA
TION KIT, Litton Bionetics, Kensington, Md.) was followed with the excep
tion that the initial serum dilution was 1:8, not 1:100 as specified in
the package protocol.
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Indirect Fluorescent-Antibody Assay
For the IFA test, the AD-169 strain of CMV was cultured on L-645 hu
man lung fibroblasts until 70% cytopathic effect was noted (approximately
120 hrs. post infection).

The cells were then dislodged with 0.25% tryp

sin, washed twice with phosphate-buffered saline (PBS; 0.15M, pH 7.2) and
adjusted to a final concentration of approximately 10

7

cells per ml.

One

drop of cell suspension was placed on circumscribed areas of glass slides
and air dried.

The air dried slides were then fixed with cold acetone for

15 minutes at 4°C and stored frozen at -70°C until needed for the test it
self.
Sera were diluted in PBS and serial twofold dilutions were prepared
from 1:8 through 1:256.

Each dilution was individually applied dropwise

to a focus of dried infected cells and the slides placed in a moist chamber for 20 minutes at 37°C.

The preparations were washed twice with PBS

and then overlaid with a drop of goat fluorescein-conjugated anti-human
immunoglobulin G (Meloy Laboratories, Springfield, Va. Lot #78077) for 20
minutes at 37°C.

(Conjugates were first titrated against previously de

fined known positive serum to determine the optimal dilution for use.)
The conjugate was removed, the cells were washed in PBS as before, and the
preparations were covered with 25% glycerin in

PBS at pH 9.

Positive and

negative serum controls were included on each slide.
A positive reaction was indicated by specific nuclear fluorescence
observed by microscopic examination with ultraviolet light.

The antibody
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level was expressed as the dilution or titer which maintained a 1+ fluorescence as determined by the reader.

The IFA test as performed in this

study was a well standardized IFA procedure commonly used to detect the
presence of antibody to CMV (15).
Indirect Hemagglutination Assay
The IHA procedure was performed as outlined by Yeager (13).

This

procedure differed from earlier IHA tests for CMV (14) in that glutaraldehyde-fixed, human type 0 erythrocytes rather than sheep erythrocytes were
used.

This method offered the advantage of freezing glutaraldehyde-fixed.

tanned, sensitized cells for long periods until needed for the test.
procedure was carried out in several steps.

The

Freshly drawn whole human

blood from a donor with type 0 erythrocytes was mixed with sodium citrate.
washed several times in PBS and fixed in 1% glutaraldehyde (EM grade. Sigma
Chemical Co. St. Louis, Mo.) for 30 minutes.

After fixation, the cells

were again washed and could be used immediately or stored frozen at -70°C
for up to six months.

The antigen used was prepared from CMV strain AD-169

grown in human foreskin fibroblasts.
thaw extraction technique.

Yeager's procedure specified a freeze-

We extracted the antigen by sonic treatment of

the infected cell suspension after a cycle of freezing and thawing.
The optimal dilution of antigen was determined by titrating the anti
gen against known positive sera using cells treated with the optimal tannic acid concentration for each cell batch.
was 1:8 in our preparation.

The optimal antigen dilution

The optimal tannic acid concentration was det-

ermined for each cell batch by testing known positive and negative sera
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against cells with tannic acid concentrations in the range of 1:20,000 to
1:320,000 (wt/vol) and sensitized with the optimal dilution of antigen.
The optimal tannic acid concentration in our test system was 1:40,000.
Once the correct antigen and tannic acid concentrations were determined.
the fixed, tanned, sensitized human 0 erythrocytes and control cells
(cells treated in like manner but not sensitized with CMV antigen) were
stored frozen until needed for the test.

The test itself was easily per-

formed.
The cells were added to serial twofold dilutions of serum in 0.15M
PBS (pH 7.2) containing 1% normal rabbit serum and .1M lysine.
dilutions ranged from 1:8 to 1:1024.

The serum

The cells were allowed to settle for

forty five minutes at room temperature and read.

The titer was considered

to be the highest dilution of serum that caused a 3+ to 4+ agglutination.

RESULTS
The results, summarized in Table 1, are expressed as the reciprocal
of the dilutions obtained as titers in the various tests.

The sera are

arranged according to increasing CF titers since the CF test served as our
baseline data against which all other procedures were compared.
Two samples (#42 and #411) gave low CF titers but were negative in
each of the other three test systems.

Two samples (#777 and #1231) were

anticomplementary (AC) in the CF test even after several attempts to elim
inate the anticomplementary activity.

It is interesting to note that one

of the AC samples was measured as a high-titered positive in the other
test procedures and the other AC sample was shown to be negative.
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With the exception of these four samples, all sera that were positive
in one test system were also positive in each of the other tests.

Con-

versly, all sera giving negative results in one test, gave the same result
in each of the other methods.

The results given by all tests on these

sera were qualitatively the same.
The titers obtained demonstrated the quantitative differences between
the four methods.

The CF test generally gave lower titers than the other

procedures examined.

In Figure 1, the CF titers are compared directly

with the titers obtained by the ELISA, IFA, and IHA assays.

These data

demonstrate that each of these procedures offered a higher degree of sen
sitivity than did the CF test as evidenced by the consistently higher ti
ters obtained.

The AC sera were excluded from Figure 1.

The IHA titer

was carried out to a 1:1024 dilution as specified by the procedure while
all other methods were carried out only to a 1:256 dilution.
Figure 2 shows a comparison of titers obtained by the ELISA, IFA, and
IHA tests.

It can be seen that the titers obtained by these three methods

demonstrated a high degree of correlation.

This correlation was analysed

statistically using Spearman's rank correlation method and the results are
presented in Table 2.

The high correlation coefficients (r) obtained sugg

est that the four procedures are measuring similar antibody to CMV.

The

higher degree of correlation between the ELISA, IFA, and IHA results (r val
ues above .8) are in contrast to the lower correlation coefficients obtained
when comparing the CF test results with the other procedures (r values be
tween .4 and .6).

Reliable coefficients of correlation ranging from .4 to
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.6 may be regarded as indicating a moderate degree of correlation while
values from .8 to 1.0 indicate a high correlation (16).
Figure 3 shows the distributions of the titers obtained by each method.

It is evident that the titers from the ELISA, IFA, and IHA assays are

more sensitive than the titers from the CF test.

These differences are

reflected in the geometric mean titers (GMTs) calculated for each test.
The GMTs for the ELISA, IFA, and IHA tests do not differ significantly
from one another but they are all significantly greater than the GMT calculated for the CF test.

For the sake of comparison, all titers greater

than 1:256 in the IHA test are grouped in the 1:256 category.

DISCUSSION
It has been estimated that 66% of the general population of the United
States shows serologic evidence of CMV infection (17) and 12% of all blood
In a routine sampling

donors are capable of transmitting the virus (18).

of 1000 units of blood, 21% had significant titers (1:8 or greater) of CF
antibody to CMV (19).

The presence of antibody to CMV does not necessar-

ily mean that one is a carrier of the virus (20) but there is a definite
positive correlation between transfusion-acquired CMV infection and the
presence of antibody.

The amount of blood received is also a factor in

establishing CMV infection via blood donors (6,21).
The CF test, although widely used, may have several limitations as a
diagnostic procedure.

The sensitivity of the assay is uncertain and small

quantities of antibody may not be detected (22,23).
detects the presence of specific IgG antibodies.

The CF test primarily

Not all subclasses
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of IgG fix complement (24) and IgM apparently reacts poorly in the CF test
as used for CMV (25).
and its

A negative CF test does not rule out CMV infection

usefulness in screening prospective blood donors is limited.

Our results support the conclusions of other investigators that the
CF test lacks sensitivity (26,29).

The CF titers were consistently lower

than the titers achieved with the other methods.

All of the sera that

were positive in the ELISA, IFA, and IHA tests were also positive in the
CF test with the exception of the two AC samples.

From this standpoint,

the CF test was adequate in detecting CMV antibody but did so at a lower
level of sensitivity.

The AC samples demonstrated another problem with

the CF procedure in that not all sera give acceptable results in the test.
Anticomplementary sera are those reading less than 75% hemolysis in the
serum control without antigen.

Samples #42 and #411 resulted in CF titers

of 1:8 and 1:16 respectively, but were negative in all other assays examined.

The CF testing was done prior to the other procedures.

It is poss-

ible that additional freezing and thawing of these samples adversely affected the ELISA, IFA, and IHA results.

A repeat CF assay was not performed

on these two samples due to insufficient sample.

It was noted that there

was an occasional decrease in titer when certain sera had undergone repeat
ed cycles of freezing and thawing.
It is also possible that the CF test may be detecting specific anti
bodies that are somehow different from those detected by other assays (26).
It has been proposed that "early" antibody from recent CMV infections may
result in different antigen binding properties from those usually encountered.
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or that these types of results may reflect differences in the antigens of
the test systems (14).

The sensitivity of the test may be increased by

using a glycine extraction technique for the antigen preparation.

The

glycine-extracted antigen may result in higher CF titers and CMV antibod
ies may be detected more frequently (27).
The ELISA technique has been adapted to a variety of test systems
for measuring antibody to CMV.

The flexibility of the assay has been

adequately demonstrated by one investigator who evaluated seven different
ELISA assays for antibody to CMV (29).

The ELISA technique has been shown

to be effective in detecting and titrating CMV antibody (30).

Both IgG

(30) and IgM (30,31) antibodies to CMV have been demonstrated by this procedure.

The sensitivity of the test is reported to be high and the titers

obtained compare favorably with both the IFA (30) and the IHA (32) proced
ures .
In the present study, the ELISA was found to be easily performed.
All controls, reagents, and test materials were available from the manufacturer (Litton Bionetics, Kensington, Md.) in kit form.

As was shown in

the results, the ELISA demonstrated the highest degree of sensitivity in
comparison with the other methods examined.

The ELISA test was the most

practical procedure based on ease of handling, speed (less than 4 hrs.),
and interpretation of results.

In order to make titer comparisons with

all four methods, sera were diluted 1:8 through 1:256.

This was contrary

to the manufacturer's recommendation to use dilutions from 1:100 through
1:6400.

The lower dilutions presented no difficulty in interpretation.
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Two samples (#234 and #188) gave ELISA titers less than 1:100.

The manu

facturer's claim that a 1:8 CF titer is equal to a 1:100 ELISA titer was
not supported by these results.
The IFA test is reported to be more sensitive than the CF test (33,34)
and can be used to effectively screen blood for antibody to CMV (5) .

CMV

infection of human fibroblasts induces an Fc receptor in the cytoplasm of
infected cells which may non-specifically bind IgG.

This can result in

false positive reactions with certain samples (15).

Non-specific staining

can be minimized by using isolated nuclei for target antigens (35) or the
test can be performed as an anticomplement immunofluorescence procedure
(36) .
The IFA procedure compares well with the IHA test and may be more
sensitive (39).
than IgG (37,38).

It can also be used to measure antibody classes other
Our results indicated a high degree of correlation

with both the ELISA and IHA procedures (Figure 2).

Training individuals

to competently read the IFA test may be time consuming.

With experience,

one can learn to correctly distinguish between specific nuclear staining
and non-specific cytoplasmic staining.

The IFA test is rapid (less than

2 hrs.) and convenient to use once the slides have been prepared.
The IHA test is also a highly sensitive and reproducible procedure.
The test is more sensitive than the CF test (14,40) and IgM antibodies
• to CMV can be assayed for as well as IgG.
with the IFA and ELISA procedures.

The IHA system correlates well

It has an additional advantage in that

IHA antibodies are some of the first to appear in a CMV infection (41).
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The IHA titers being higher than the CF titers may be due to fundamental
differences in the antigens used in the tests (42).

The modified IHA pro

cedure that we used (13) utilizes human type 0 erythrocytes and permits
storage of fixed, tanned, sensitized cells frozen for up to eight months.
Long term storage of CMV sensitized sheep cells has been one of the major
limitations of the standard IHA procedure.

Recently, the use of freeze-

dried sensitized cells has been perfected and is being advocated (43).
The IHA test itself is a rapid procedure (45 minutes) and the test
iseasily performed.

The test can be used effectively to screen large num-

bers of sera for CMV.

The preparation and pH of the various buffers were

found to be critical for proper results.

The tannic acid titration was an

exacting procedure and not all of our human 0 cell batches would work in
the test (4 out of 7).
be titrated seperately.

Each batch of cells reacted differently and had to
It is also of interest that glycine-extracted

antigen failed to perform satisfactorily in the IHA procedure.

It was due

to these types of problems that the test was not considered to be a prac
tical method in our laboratory.
In conclusion, the CF test was found to be the least sensitive method
used but it's effectiveness may still be valid as there were two samples
that were positive by no other procedure.

The ELISA was shown to be the

most sensitive test and was also the easiest to use.

The results of the

IFA and IHA tests were comparable to the ELISA but these procedures were
shown to be less desirable from a practical standpoint.

As a result of

this study the virology laboratory at Loma Linda University Medical Center
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will be using the ELISA technique when assaying sera for antibodies to
CMV.
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SUMMARY OF TITERS OF FOUR METHODS
TABLE 1
OF MEASURING ANTIBODY TO CYTOMEGALOVIRUS
SAMPLE #

CF TITER

ELISA TITER

IFA TITER

■IHA TITER

152
184
199
221
286
315
347
388
429
445
503
863
959
42
234
411
424
606
154
553
637
894
135
156
162
188
617
640
837
1222
390
410
418
1170
106
269
333
373
449
474
1186

<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
8
16
16
16
16
32
32
32
32
64
64
64
64
64
64
64
64
128
128
128
128
256
256
256
256
256
256
256

<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
32
<8
128
256
256
256
128
128
256
128
128
64
256
256
256
256
256
256
256
256
256
256
128
256
256
128
256

<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
64
<8
256
32
256
64
64
128
128
64
128
128
128
128
128
64
128
256
128
128
256
256
128
256
256
128
256

<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
64
<8
128
64
512
128
64
64
512
128
256
128
64
64
128
256
128
512
256
512
1024
512
64
512
512
64
128

777
1231

AC
AC

256
<8

64
<8

128
<8
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TABLE 2 - CORRELATION BETWEEN SPECIFIC ANTIBODY TITERS DETECTED
IN 43 SERA BY THE CF, ELISA, IFA, AND IHA TESTS FOR CMV.

COMPARATIVE ASSAYS by:

CORRELATION COEFFICIENT (r)*

CF and ELISA
CF and IFA
CF and I HA

+ .41
+ .54
+ .56

ELISA and IFA
ELISA and IHA
IFA and IHA

+ .89
+ .90
+ .87

* Correlation coefficient (r) calculated by Spearman's
rank correlation method.
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FIGURE LEGENDS

Fig. 1.

Comparison of CMV Antibody titers obtained in the CF, ELISA,

IFA, and IHA tests.

Fig. 2.

Comparison of CMV Antibody titers obtained in the ELISA, IFA,

and IHA tests.

Fig. 3.

Distribution and Geometric Mean Titers obtained in the CF,

IFA, IHA, and ELISA tests for CMV.
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